|Berries on the blushwood tree, a plant only found in specific areas of the Atherton|
Tablelands in tropical north Queensland. Photograph: QIMR Berghofer Medical
"The Akashic System of Remembrance" - Sep 2010 (Kryon Channelling) - Reference to Whales/Dolphins/Animals/Pets .. > 28:00 min
"The Greater Akashic System" – July 15, 2012 (Kryon Channelling by Lee Caroll) (Subjects: Lightworkers, Intent, To meet God, Past lives, Universe/Galaxy, Earth, Pleiadians, Souls Reincarnate, Invention: Measure Quantum state in 3D, Recalibrates, Multi-Dimensional/Divine, Akashic System to change to new system, Before religion changed the system, DNA, Old system react to Karma, New system react to intent now for next life, Animals (around humans) reincarnate again, This Animal want to come back to the same human, Akashic Inheritance, Reincarnate as Family, Other Planets, Global Unity … etc.)
Question: Dear Kryon: I live in Spain. I am sorry if I will ask you a question you might have already answered, but the translations of your books are very slow and I might not have gathered all information you have already given. I am quite concerned about abandoned animals. It seems that many people buy animals for their children and as soon as they grow, they set them out somewhere. Recently I had the occasion to see a small kitten in the middle of the street. I did not immediately react, since I could have stopped and taken it, without getting out of the car. So, I went on and at the first occasion I could turn, I went back to see if I could take the kitten, but it was to late, somebody had already killed it. This happened some month ago, but I still feel very sorry for that kitten. I just would like to know, what kind of entity are these animals and how does this fit in our world. Are these entities which choose this kind of life, like we do choose our kind of Human life? I see so many abandoned animals and every time I see one, my heart aches... I would like to know more about them.
Answer: Dear one, indeed the answer has been given, but let us give it again so you all understand. Animals are here on earth for three (3) reasons.
(1) The balance of biological life. . . the circle of energy that is needed for you to exist in what you call "nature."
(2) To be harvested. Yes, it's true. Many exist for your sustenance, and this is appropriate. It is a harmony between Human and animal, and always has. Remember the buffalo that willingly came into the indigenous tribes to be sacrificed when called? These are stories that you should examine again. The inappropriateness of today's culture is how these precious creatures are treated. Did you know that if there was an honoring ceremony at their death, they would nourish you better? Did you know that there is ceremony that could benefit all of humanity in this way. Perhaps it's time you saw it.
(3) To be loved and to love. For many cultures, animals serve as surrogate children, loved and taken care of. It gives Humans a chance to show compassion when they need it, and to have unconditional love when they need it. This is extremely important to many, and provides balance and centering for many.
Do animals know all this? At a basic level, they do. Not in the way you "know," but in a cellular awareness they understand that they are here in service to planet earth. If you honor them in all three instances, then balance will be the result. Your feelings about their treatment is important. Temper your reactions with the spiritual logic of their appropriateness and their service to humanity. Honor them in all three cases.
Friday, October 10, 2014
Cancer tumours destroyed by berry found in Queensland rainforest
Drug derived from the fruit of the blushwood tree kills cancerous tumours long-term in animals in 70% of cases
Scientists have managed to destroy cancerous tumours by using an experimental drug derived from the seeds of a fruit found in north Queensland rainforests.
The drug, called EBC-46, was produced by extracting a compound from the berry of the blushwood tree, a plant only found in specific areas of the Atherton Tablelands.
A single injection of the drug directly into melanoma models in the laboratory, as well as into cancers of the head, neck and colon in animals, destroyed the tumours long-term in more than 70% of cases, the study’s lead author, Dr Glen Boyle, said.
“In preclinical trials we injected it into our models and within five minutes, you see a purpling of the area that looks like a bruise,” Boyle, from the QIMR Berghofer Medical Research Institute said.
“About 24 hours later, the tumour area goes black, a couple of days later you see a scab, and at around the 1.5 week mark, the scab falls off, leaving clean skin with no tumour there. The speed certainly surprised me.”
Researchers believe the drug triggers a cellular response which cuts off the blood supply to the tumour by opening it up.
“That’s why we see a bruise-like situation forming in the tumour,” Boyle said. “This seems to lead to an activation of the body’s own immune system which then comes in and cleans up the mess.”
It has been used by veterinarians in about 300 cases of cancer in companion animals including dogs, cats and horses.
There was no evidence EBC-46 would be effective to treat cancers that had spread to other parts of the body, known as metastatic cancers, Boyle said.
The drug is being developed as a human and veterinary pharmaceutical through QBiotics, a subsidiary of the company which discovered the drug, called EcoBiotics. The company is also examining the potential for a blushwood plantation.
Ethical approval was recently granted for phase 1 human clinical trials, but even if those proved successful, it was unlikely the drug would replace conventional chemotherapy treatment, Boyle said.
“Chemotherapy is still used because it is very effective for a lot of people,” he said. “But EBC-46 could perhaps be used in people who, for some reason, chemotherapy doesn’t work [for], or for elderly patients whose body can’t sustain another round of chemotherapy treatment.”
The preclinical trial was funded by QIMR Berghofer and the National Health and Medical Research Council and the results were published in the journal PLOS One.